Literature DB >> 17527044

Do the effects of long-term lomerizine administration differ with age?

Noboru Imai1, Takashi Konishi, Masahiro Serizawa, Takashi Okabe.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17527044     DOI： 10.2169/internalmedicine.46.6409

Source DB:  PubMed          Journal:  Intern Med        ISSN： 0918-2918            Impact factor:   1.271


× No keyword cloud information.
  2 in total

1.  Treatment with telmisartan, a long-acting angiotensin II receptor blocker, prevents migraine attacks in Japanese non-responders to lomerizine.

Authors:  Ken Ikeda; Sayori Hanashiro; Yuichi Ishikawa; Masahiro Sawada; Maya Kyuzen; Harumi Morioka; Junya Ebina; Junpei Nagasawa; Masaru Yanagihashi; Ken Miura; Takehisa Hirayama; Takanori Takazawa; Osamu Kano; Kiyokazu Kawabe; Yasuo Iwasaki
Journal:  Neurol Sci       Date:  2017-02-21       Impact factor: 3.307

2.  Alleviation of brain hypoperfusion after preventative treatment with lomerizine in an elderly migraineur with aura.

Authors:  Joe Aoyagi; Ken Ikeda; Tetsuhito Kiyozuka; Takehisa Hirayama; Yuichi Ishikawa; Ryuta Sato; Yasuhiro Yoshii; Kiyokazu Kawabe; Yasuo Iwasaki
Journal:  Int J Mol Imaging       Date:  2010-12-27
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.